Top

International Journal of Clinical Oncology

Published in:

01-04-2016 | Original Article

Relationship between quality of life instruments and phonatory function in tracheoesophageal speech with voice prosthesis

Authors: Masayuki Miyoshi, Takahiro Fukuhara, Hideyuki Kataoka, Hiroshi Hagino

Published in: International Journal of Clinical Oncology | Issue 2/2016

Abstract

Background

The use of tracheoesophageal speech with voice prosthesis (T-E speech) after total laryngectomy has increased recently as a method of vocalization following laryngeal cancer. Previous research has not investigated the relationship between quality of life (QOL) and phonatory function in those using T-E speech. This study aimed to demonstrate the relationship between phonatory function and both comprehensive health-related QOL and QOL related to speech in people using T-E speech.

Methods

The subjects of the study were 20 male patients using T-E speech after total laryngectomy. At a visit to our clinic, the subjects underwent a phonatory function test and completed three questionnaires: the MOS 8-Item Short-Form Health Survey (SF-8), the Voice Handicap Index-10 (VHI-10), and the Voice-Related Quality of Life (V-RQOL) Measure.

Results

A significant correlation was observed between the physical component summary (PCS), a summary score of SF-8, and VHI-10. Additionally, a significant correlation was observed between the SF-8 mental component summary (MCS) and both VHI-10 and VRQOL. Significant correlations were also observed between voice intensity in the phonatory function test and both VHI-10 and V-RQOL. Finally, voice intensity was significantly correlated with the SF-8 PCS.

Conclusions

QOL questionnaires and phonatory function tests showed that, in people using T-E speech after total laryngectomy, voice intensity was correlated with comprehensive QOL, including physical and mental health. This finding suggests that voice intensity can be used as a performance index for speech rehabilitation.

Aronson AE, Bless DM (2009) Clinical voice disorders. Thieme, New York, p 37

Clements KS, Rassekh CH, Seikaly H et al (1997) Communication after laryngectomy. An assessment of patient satisfaction. Arch Otolaryngol Head Neck Surg 123(5):493–496CrossRefPubMed

Hilgers FJ, Schouwenburg PF (1990) A new low-resistance, self-retaining prosthesis (Provox) for voice rehabilitation after total laryngectomy. Laryngoscope 100(11):1202–1207. doi:10.1288/00005537-199011000-00014 CrossRefPubMed

Op de Coul BM, Hilgers FJ, Balm AJ et al (2000) A decade of postlaryngectomy vocal rehabilitation in 318 patients: a single institution’s experience with consistent application of Provox indwelling voice prostheses. Arch Otolaryngol Head Neck Surg 126(11):1320–1328CrossRefPubMed

Eadie TL, Doyle PC (2005) Quality of life in male tracheoesophageal (TE) speakers. J Rehabil Res Dev 42(1):115–124PubMed

Rossi VC, Fernandes FL, Ferreira MA et al (2014) Larynx cancer: quality of life and voice after treatment. Braz J Otorhinolaryngol 80(5):403–408. doi:10.1016/j.bjorl.2014.07.005 CrossRefPubMed

Rosen CA, Lee AS, Osborne J et al (2004) Development and validation of the Voice Handicap Index-10. Laryngoscope 114(9):1549–1556. doi:10.1097/00005537-200409000-00009 CrossRefPubMed

Hogikyan ND, Sethuraman G (1999) Validation of an instrument to measure Voice-Related Quality of Life (V-RQOL). J Voice 13(4):557–569CrossRefPubMed

Portone CR, Hapner ER, McGregor L et al (2007) Correlation of the Voice Handicap Index (VHI) and the Voice-Related Quality of Life Measure (V-RQOL). J Voice 21(6):723–727. doi:10.1016/j.jvoice.2006.06.001 CrossRefPubMed

10.

WHO (World Health Organization) (1997) Measuring quality of life––the World Health Organization quality of life instruments. WHO, Geneva, pp 1–15

11.

Kaji M, Fujiwara Y, Shiba M et al (2010) Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol 25(6):1151–1156. doi:10.1111/j.1440-1746.2010.06249.x CrossRefPubMed

12.

Shim EJ, Mehnert A, Koyama A et al (2006) Health-related quality of life in breast cancer: a cross-cultural survey of German, Japanese, and South Korean patients. Breast Cancer Res Treat 99(3):341–350. doi:10.1007/s10549-006-9216-x CrossRefPubMed

13.

Bozec A, Poissonnet G, Chamorey E et al (2010) Results of vocal rehabilitation using tracheoesophageal voice prosthesis after total laryngectomy and their predictive factors. Eur Arch Otorhinolaryngol 267(5):751–758. doi:10.1007/s00405-009-1138-x CrossRefPubMed

14.

Fukuhara T, Fujiwara K, Nomura K et al (2013) New method for in-office secondary voice prosthesis insertion under local anesthesia by reverse puncture from esophageal lumen. Ann Otol Rhinol Laryngol 122(3):163–168CrossRefPubMed

15.

Ware JE, Kosinski M, Dewey JE et al (2001) How to score and interpret single-item health status measures: a manual for users of the SF-8 health survey. Quality Metric Inc., Lincoln, RI

16.

Wu C, Volk RJ, Steinbauer JR et al. (2003) A wireless mobile health-related quality of life assessment. AMIA Annu Symp Proc 1:1054

17.

Shanafelt TD, West C, Zhao X et al (2005) Relationship between increased personal well-being and enhanced empathy among internal medicine residents. J Gen Intern Med 20(7):559–564. doi:10.1111/j.1525-1497.2005.0108.x CrossRefPubMedPubMedCentral

18.

Lefante JJ Jr, Harmon GN, Ashby KM et al (2005) Use of the SF-8 to assess health-related quality of life for a chronically ill, low-income population participating in the Central Louisiana Medication Access Program (CMAP). Qual Life Res 14(3):665–673CrossRefPubMed

19.

Fukuhara S, Suzukamo Y (2004) Manual of the SF-8 Japanese Version (in Japanese). Institute for Health Outcomes and Process Evaluation Research, Kyoto

20.

Shiozaki M, Hirai K, Dohke R et al (2008) Measuring the regret of bereaved family members regarding the decision to admit cancer patients to palliative care units. Psychooncology 17(9):926–931. doi:10.1002/pon.1312 CrossRefPubMed

21.

Shibata A, Oka K, Nakamura Y et al (2007) Recommended level of physical activity and health-related quality of life among Japanese adults. Health Qual Life Outcomes 5:64. doi:10.1186/1477-7525-5-64 CrossRefPubMedPubMedCentral

22.

Uramoto H, Kagami S, Iwashige A et al (2007) Evaluation of the quality of life between inpatients and outpatients receiving cancer chemotherapy in Japan. Anticancer Res 27(2):1127–1132PubMed

23.

Jacobson B, Johnson A, Grywalski C et al (1997) The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol 6:66–70CrossRef

24.

Shiromoto O, Ikenaga E (2011) Reliability and validity of VHI (Voice Handicap Index) and V-RQOL (Voice-Related Quality Of Life): Japanese versions. Jpn J Logop Phoniatr 52(3):254–262CrossRef

25.

Kimura K, Kiyokawa H, Yonaiyama C et al (1989) Psychological condition followed by phonatory dysfunction. J Jpn Soc Nurs Res 12(4):9–14

26.

Kawamura Y, Okamura H, Yumoto E (1986) Multiparametric display of vocal dysfunction: use of radar chart. J Otolaryngol Jpn 89(4):448–454

27.

Fujimoto T, Kinishi M, Mohri M et al (1994) Mechanism of neoglottic adjustment for voice variation in tracheoesophageal speech. J Otolaryngol Jpn 97:1009–1018

28.

Kinishi M, Amatsu M (1986) Aerodynamic studies of laryngectomees after the Amatsu tracheoesophageal shunt operation. Ann Otol Rhinol Laryngol 95(2 pt 1):181–184CrossRefPubMed

29.

Hasegawa T, Kinishi M, Mohri M et al (2001) Vibratory source and mechanism in tracheojejunal phonation. J Jpn Bronchoesophagol Soc 52:17–23CrossRef

30.

Cohen SM, Dupont WD, Courey MS (2006) Quality-of-life impact of non-neoplastic voice disorders: a meta-analysis. Ann Otol Rhinol Laryngol 115(2):128–134CrossRefPubMed

Title: Relationship between quality of life instruments and phonatory function in tracheoesophageal speech with voice prosthesis
Authors: Masayuki Miyoshi
Takahiro Fukuhara
Hideyuki Kataoka
Hiroshi Hagino
Publication date: 01-04-2016
Publisher: Springer Japan
Published in: International Journal of Clinical Oncology / Issue 2/2016
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-015-0886-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2016

Optimal strength and timing of steroids in the management of erlotinib-related skin toxicities in a post-marketing surveillance study (POLARSTAR) of 9909 non-small-cell lung cancer patients

Increased risk of certain second primary malignancies in patients treated for well-differentiated thyroid cancer

R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy

Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers

The processus vaginalis transection method is superior to the simple prophylactic procedure for prevention of inguinal hernia after radical prostatectomy

Human collagen XV is a prominent histopathological component of sinusoidal capillarization in hepatocellular carcinogenesis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer